Form 4: cbdMD Director Bakari T. Sellers Reports Acquisition and Disposal of Shares
SEC Form 4
Director Bakari T. Sellers reports acquiring 4,000 shares of common stock and disposing of 4,000 shares, along with acquiring stock options for 2,000 shares, as compensation for board service.
Summary
- On March 29, 2024, Bakari T. Sellers, a director of cbdMD, Inc. (YCBD), reported acquiring 4,000 shares of common stock.
- These shares were acquired at a price of $0.
- Sellers also disposed of 4,000 shares of common stock.
- Following these transactions, Sellers beneficially owns 9,438 shares.
- Additionally, Sellers acquired stock options for 2,000 shares with an exercise price of $0.93, which are fully vested and expire on March 29, 2029.
- These transactions were part of compensation for Sellers' service on the Board of Directors, approved by the Compensation, Corporate Governance and Nominating Committee.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and alignment of director interests with the company. There are no indications of negative events or concerns.
Positives
- The acquisition of restricted stock units and stock options indicates continued alignment of the director's interests with the company's performance.
- The grants were approved by the Compensation, Corporate Governance and Nominating Committee, suggesting proper governance oversight.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash, stock options, and restricted stock units to align their interests with shareholders.
- The vesting schedule for the restricted stock units is typical for director compensation, encouraging long-term commitment.
- The approval of the grants by the Compensation Committee is a standard corporate governance practice.
Stakeholder Impact
- The transactions have a minor positive impact on shareholders by aligning director interests with company performance.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Date of transaction: Acquisition and disposal of common stock, and grant of stock options. |
| 03/29/2029 | Expiration date of the stock options. |
| 06/30/2024 | First vesting date for restricted stock units. |
| 09/30/2024 | Second vesting date for restricted stock units. |
| 12/31/2024 | Third vesting date for restricted stock units. |
| 03/31/2025 | Final vesting date for restricted stock units. |
| 04/02/2024 | Date of signature on the Form 4. |
Keywords
cbdMD, Bakari T. Sellers, Director, Form 4, Stock Options, Restricted Stock Units, YCBD, Beneficial Ownership, Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.